Alzheimer's disease & dementia

Alzheimer's and aducanumab: Unjust profits and false hopes

The U.S. Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's disease raises at least three major ethical issues that need to be addressed, states a new article in the ...

Diseases, Conditions, Syndromes

Delta variant reignites US mask debate

The recent surge of COVID-19, driven by the Delta variant, has reignited political controversy around mask-wearing in the United States, with some governors opposing all measures to make masks mandatory despite advice from ...

page 4 from 5